Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0298079 THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
This invention relates to thieno[3,2-d]pyrimidines derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral...
2017/0298078 METHODS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS
In general, the present invention features improved methods useful for the synthesis of analogs of halichondrin B, such as eribulin and pharmaceutically...
2017/0298077 HETEROCYCLIC COMPOUNDS WITH BENZO(C)COUMARIN-STRUCTURES
The invention relates to heterocyclic compounds with benzo[c]coumarin structures and to electronic devices, in particular organic electroluminescent devices,...
2017/0298076 PHARMACOLOGICALLY ACTIVE COMPOUNDS
The present invention relates to compounds of formula I shown below: ##STR00001## wherein Q is as defined herein. The compounds of formula I act as selective...
2017/0298075 TETRAHYDROISOQUINOLINE DERIVED PRMT5-INHIBITORS
A compound of formula I wherein: n is 1 or 2: p is 0 or 1; R.sup.1 is optionally one or more halo or methyl groups; R.sup.2a and R.sup.2b are independently...
2017/0298074 NOVEL COMPOUNDS AS REARRANGED DURING TRANSFECTION (RET) INHIBITORS
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing...
2017/0298073 SALTS, CO-CRYSTALS, AMORPHOUS FORMS, AND CRYSTALLINE FORMS OF A CO-ACTIVATOR-ASSOCIATED ARGININE...
Provided herein are solid forms (e.g., salts, co-crystals, amorphous forms, and crystalline forms) of methyl ...
2017/0298072 Triazolopyrazinones as PDE1 Inhibitors
The present invention provides triazolopyrazinones as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative...
2017/0298071 COMPOUND
The present invention relates to a salt form of a benzodiazepine derivative, in particular crystalline solid state forms, to pharmaceutical compositions...
2017/0298070 NOVEL CHIRAL SYNTHESIS OF N-ACYL-(3-SUBSTITUTED)-(8-SUBSTITUTED)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]- PYRAZINES
Disclosed is a novel chiral synthesis of N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]- pyrazines of Formula (I), avoiding the use...
2017/0298069 INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and...
2017/0298068 NOVEL FXR (NR1H4) MODULATING COMPOUNDS
The present invention relates to compounds which bind to the NR1H4 receptor (FXR) and act as agonists of FXR. The invention further relates to the use of the...
2017/0298067 NOVEL TETRAHYDROPYRIDOPYIMIDINES AND TETRAHYDROPRIDOPYRIDOPYRIDINES FOR THE TREATMENT AND PROPHYLAXIS OF...
The invention provides novel compounds having the general formula: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, Q, U,W, Z, X and Y are as described herein,...
2017/0298066 1 -(5-TERT-BUTYL-2-ARYL-PYRAZOL-3-YL)-3-[2-FLUORO-4-[(3-OXO-4H-PYRIDO[2, 3-B]PYRAZIN-8-YL)OXY]PHENYL]UREA...
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain ...
2017/0298065 PROCESS FOR THE PREPARATION OF 8-(4-AMINOPHENOXY)-4H-PYRIDO[2,3-B]PYRAZIN-3-ONE DERIVATIVES
The present invention pertains generally to the field of organic chemical synthesis, and in particular to certain methods for the synthesis of ...
2017/0298064 PROCESS FOR PREPARING HALOGENATED AZAINDOLE COMPOUNDS USING BOROXINE
A process for preparing halogenated azaindole compounds makes use of stable reagents including a brominating reagent, a boroxine and a sulfonic anhydride to...
2017/0298063 NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
A compound of formula (I): ##STR00001## wherein R is H or F; or a salt thereof.
2017/0298062 N-PYRIDINYL ACETAMIDE DERIVATIVES AS WNT SIGNALLING PATHWAY INHIBITORS
Disclosed are compounds useful as inhibitors of the Wnt signalling pathway. Specifically, inhibitors of Porcupine (Porcn) are contemplated by the invention. In...
2017/0298061 FUSED BICYCLIC (HETERO)AROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF CANCERS
This invention relates to novel compounds. The compounds of the invention are kinase inhibitors. Specifically, the compounds of the invention are useful as...
2017/0298060 PYRROLOPYRIDINE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR MODULATORS AND USES THEREOF
Provided herein are compounds of the formula (I): ##STR00001## as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those...
2017/0298059 COMPOUNDS FOR BONE GROWTH
In one aspect, the invention provides compounds of Formula I, and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of...
2017/0298058 HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE
The present invention provides novel compounds having a P2X.sub.3 and/or P2X.sub.2/3 receptor antagonistic effect, e.g. a compound of Formula (I): ##STR00001## ...
2017/0298057 DEUTERATED O-SULFATED BETA LACTAM HYDROXAMIC ACIDS AND DEUTERATED N- SULFATED BETA LACTAMS
Provided herein are deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams, pharmaceutical compositions thereof and methods...
2017/0298056 SMALL MOLECULE INHIBITORS OF HIV-1 ENTRY AND METHODS OF USE THEREOF
Described herein are small-molecule compounds that specifically inhibit a wide range of HIV-1 isolates without interfering with CD4 or CCR5 binding. Methods of...
2017/0298055 sGC STIMULATORS
The present patent application discloses at least the compounds according to Formula Ia and Formula Ib shown below, or pharmaceutically acceptable salts...
2017/0298054 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which...
2017/0298053 NOVEL N-[(PYRIMIDINYLAMINO)PROPANYL]-AND N [(PYRAZINYLAMINO)PROPANYL]ARYLCARBOXAMIDES
The present invention relates to novel N-[(Pyrimidinylamino)propanyl]- and N-[(Pyrazinylamino)-propanyl]arylcarboxamide derivatives, processes for their...
2017/0298052 SUBSTITUTED OXOPYRIDINE DERIVATIVES
The invention relates to substituted oxopyridine derivatives and to processes for preparation thereof, and also to the use thereof for production of...
2017/0298051 ACTIVATOR OF ADIPONECTIN RECEPTOR
An AdipoR activator for activating both AdipoR1 and AdipoR2 is provided. A compound represented by the following formula (1), wherein A is a substituted or...
2017/0298050 ESTER PRODRUGS OF GAMMA-LACTAMS AND THEIR USE
Described herein are ester prodrugs of gamma-lactam compounds of Formula (I): or pharmaceutically acceptable salt thereof, and methods of use of such compounds...
2017/0298049 BICYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATING STROKE AND USE THEREOF
The present disclosure relates to a bicyclic compound, a pharmaceutical composition thereof, and its novel use. More particularly, the present disclosure...
2017/0298048 SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS
This invention relates to compounds of general formula (I) ##STR00001## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, L, X and Z are as defined herein, and the...
2017/0298047 TETRAHYDROQUINOLINE DERIVATIVES AS BROMODOMAIN INHIBITORS
The present invention relates to specific novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy as bromodomain...
2017/0298046 DEUTERATED DOMPERIDONE COMPOSITIONS, METHODS, AND PREPARATION
Deuterated domperidone compositions, methods of synthesis, methods of use, and dosing formulations providing beneficial safety and other effects.
2017/0298045 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described...
2017/0298043 Indolyl-Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory Activity
Compounds of formula (I) have checkpoint kinase 1 (CHK1) inhibitory activity: ##STR00001## wherein R.sub.1, R.sub.2, R.sub.5 and R.sub.6 are independently...
2017/0298042 VMAT INHIBITORY COMPOUNDS
Disclosed herein are compounds that bind to the vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions comprising those compounds, and methods...
2017/0298041 1-ALKYL-6-OXO-1,6-DIHYDROPYRIDIN-3-YL COMPOUNDS AND USE AS SGRM MODULATORS
This specification generally relates to 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds (including salts thereof). This specification also relates to...
2017/0298040 THERAPEUTIC COMPOUNDS
The present disclosure relates to substituted heterocyclic derivative therapeutic compounds, compositions comprising said compounds, and the use of said...
2017/0298039 TRIPHASIC SYSTEM FOR DIRECT CONVERSION OF SUGARS TO FURANDICARBOXYLIC ACID
There is provided a one-pot process for the conversion of sugars to furancarboxylic acids, such as 2,5-furancarboxylic acid (FDCA), in a triphasic system (e.g....
2017/0298038 PROCESS FOR THE PREPARATION OF GAMMA-VALEROLACTONE BY CATALYTIC HYDROGENATION OF LEVULINIC ACID USING Ru-BASED...
The present invention discloses a fast and selective process for the preparation of .gamma.-valerolactone (Gvl) by catalytic hydrogenation of biomass-derived...
2017/0298037 Novel 5-Hydroxytryptamine Receptor 7 Activity Modulators and Their Method of Use
Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases...
2017/0298036 PROCESS FOR PRODUCTION OF HEXANETRIOL FROM 5-HYDROXYMETHYLFURFURAL
Industrial scale conversions of 5-hydroxymethylfurfural to commodity chemicals such as 1,2,6-hexanetriol and 1,6-hexanediol by chemocatalytic conversions using...
2017/0298035 RELATING TO ETHYLENE OXIDE RECOVERY
A process for recovering an ethylene oxide (EO) enriched product stream from fat absorbent (FA) comprising water, EO, and acetaldehyde. The process comprises...
2017/0298034 CATALYST SYSTEM FOR PREPARING PROPYLENE OXIDE
A catalytic system containing a titanium zeolite of structure type MWW optionally containing zinc and containing at least one of an inorganic potassium salt...
2017/0298033 BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS
Compounds having a structure of Formula I: ##STR00001## or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R.sup.1, R.sup.2,...
2017/0298032 SPHINGOSINE KINASE INHIBITORS
Sphingosine kinases are enzymes that catalyze the biosynthesis of sphingosine-1-phosphate. The invention provides compounds that are effective for inhibition...
2017/0298031 REACTIVE UV ABSORBER, MAKING METHOD, COATING COMPOSITION, AND COATED ARTICLE
Novel UV absorbers of benzotriazine type having a plurality of (meth)acryloxy groups have a UV absorbing capacity and a high solubility in multifunctional...
2017/0298030 FLUORESCENT PYRAZINE DERIVATIVES AND METHODS OF USING THE SAME IN ASSESSING RENAL FUNCTION
The present invention relates to pyrazine derivatives such as those represented by Formulas I and II. X.sup.1 to X.sup.4 of Formulas I and II may be...
2017/0298029 RAF KINASE MODULATOR COMPOUNDS AND METHODS OF USE THEREOF
Compounds, compositions and methods are provided for modulating the activity of RAF kinases, including BRAF kinase and for the treatment, prevention, or...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.